Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen. (Q38363907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

review article

1 reference

title

Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

main subject

Neisseria meningitidis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

Daniela Toneatto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

5

Vega Masignani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

2

Maria Scarselli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Maurizio Comanducci

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

23 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

841-859

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Meningococcal conjugate vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Complement control protein factor H: the good, the bad, and the inadequate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Microbial complement inhibitors as vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The factor H binding protein of Neisseria meningitidis interacts with xenosiderophores in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A universal vaccine for serogroup B meningococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Vaccines, reverse vaccinology, and bacterial pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Factor H-binding protein, a unique meningococcal vaccine antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Variation of the factor H-binding protein of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The modular architecture of meningococcal factor H-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Conservation of meningococcal antigens in the genus Neisseria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Transcriptional profiling of serogroup B Neisseria meningitidis growing in human blood: an approach to vaccine antigen discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Meningococcal disease and the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Structure of the uncomplexedNeisseria meningitidisfactor H-binding protein fHbp (rLP2086)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

NMR dynamics and antibody recognition of the meningococcal lipidated outer membrane protein LP2086 in micellar solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Synthetic lipopeptides as novel adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Rational design of a meningococcal antigen inducing broad protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Functional impacts of the diversity of the meningococcal factor H binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

In the NadR regulon, adhesins and diverse meningococcal functions are regulated in response to signals in human saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Multilocus sequence typing for global surveillance of meningococcal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Progressive decrease in the potential usefulness of meningococcal serogroup B vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Human immunity to the meningococcus. II. Development of natural immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningoc

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Persistence of antibodies in adolescents 18-24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1016915

10.1586/14760584.2015.1016915

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25704037%20AND%20SRC:MED&resulttype=core&format=json

release_vepqfqtgondrtfvt5vpapelgxi

1 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vepqfqtgondrtfvt5vpapelgxi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference